Skip to main content

Table 1 The characteristics of included participants

From: The role of serum β-trophin and endostatin in patients with polycystic ovary syndrome: Are they correlated?

Items PCOS group (n = 62) Control group (65) t p
Age 25.35 ± 3.58 25.11 ± 3.86 − 1.032 0.189
BMI (kg/m2) 24.28 ± 3.17 21.32 ± 3.29 4.205 0.018
WHR 0.90 ± 0.06 0.83 ± 0.05 1.127 0.011
LH (mIU/L) 9.03 ± 1.16 6.15 ± 1.12 1.184 0.009
FSH (IU/L) 5.96 ± 2.01 9.29 ± 2.15 1.202 0.013
TT (nmol/L) 2.28 ± 0.84 1.82 ± 0.71 1.047 0.025
SHBG (nmol/L) 32.83 ± 9.25 49.15 ± 8.19 − 12.184 0.015
FAI 9.70 ± 2.14 4.52 ± 1.18 2.105 0.029
AND (ng/mL) 3.94 ± 1.01 2.50 ± 0.96 1.146 0.012
FBG (mmol/L) 5.33 ± 1.13 4.66 ± 1.15 − 2.208 0.035
FINS (uIU/L) 23.29 ± 6.28 18.14 ± 2.24 2.995 0.000
HOMA-IR 3.92 ± 1.14 1.91 ± 0.97 1.028 0.007
TC (mmol/L) 4.86 ± 1.65 3.64 ± 1.90 1.136 0.015
TG (mmol/L) 1.43 ± 0.84 0.91 ± 0.11 1.177 0.023
HDL (mmol/L) 1.28 ± 0.22 1.32 ± 0.18 2.042 0.048
LDL (mmol/L) 2.83 ± 0.82 2.20 ± 0.74 1.192 0.017
β-trophin (pg/mL) 145.29 ± 30.22 99.30 ± 18.15 6.695 0.000
ES (μg/L) 313.09 ± 33.15 156.26 ± 28.85 20.150 0.000